© 2024 MJH Life Sciences™ and Patient Care Online. All rights reserved.
Grace Halsey
Articles
Comorbid Depression and IBD Significantly Increases Risk of Hospital Readmission, Mortality, According to National Database Review
January 26, 2024
Already high rates of readmission and mortality at 30 days rose significantly higher at 90 days, according to this National Readmissions Database review.
FDA Approves Dupilumab for Eosinophilic Esophagitis in Children Aged 1 to 11 Years
January 26, 2024
Dupilumab is the first agent approved to treat EoE in this vulnerable pediatric population.
Individuals with IBD Hospitalized for COVID-19 at High Risk for Shock, Organ Injury Suggests National Analysis
January 25, 2024
Among more than 1.5 million persons hospitalized for COVID-19, a history of Crohn disease or ulcerative colitis significantly increased risk for poor outcomes.
In Crohn Disease, Biologic Dose Escalation is Common During Maintenance Phase, Study Reveals
January 25, 2024
"A meaningful percentage" of individuals with Crohn disease are treated during maintenance with biologic doses ≥20%higher than recommended in FDA labeling.
Baseline HbA1c Greater than 6.0% Linked to "Exponential" Increase in T2D Risk for Adolescents with Obesity
January 24, 2024
Adolescents with overweight or obesity and baseline HbA1c 6.3%-6.4% were at 72-fold greater risk for T2D than those with HbA1c of 5.5%, a new cohort study finds.
Contraceptive Services Must be Provided without Cost-Sharing: HHS Guidance Update
January 24, 2024
Targeting "impermissible" barriers created to no-cost contraception required by the ACA, the HHS guidance follows the Biden-Harris June 2023 Executive Order on the issue.
FDA Adds Black Box to Prolia PI Warning of Severe Hypocalcemia Risk in CKD
January 23, 2024
The Boxed Warning reflects FDA research into severe adverse events including hospitalization and death in persons with CKD treated with denosumab.
Diabetes Remission of Any Duration May Reduce Risk of Renal and Cardiovascular Disease:
January 22, 2024
Remission of T2D, regardless of duration of remission, was associated with reduced risk of diabetes-related CKD and CVD in a post hoc analysis of Look AHEAD.
Gabapentinoids May Increase Risk of Severe COPD Exacerbations, Warns New Study
January 19, 2024
In persons with COPD, use of the anticonvulsants was linked to a 39% increase in risk of severe disease exacerbation requiring hospital admission, study authors reported.
"Ozempic" and Older Adults: Awareness of & Views on Rx Medications for Weight Management
January 19, 2024
When it comes overweight, obesity, and prescription drugs for weight loss, these results from the National Poll on Healthy Aging suggest older US adults need guidance.